BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22969254)

  • 1. Clinical results of high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation in children with advanced stage rhabdomyosarcoma.
    Kim NK; Kim HS; Suh CO; Kim HO; Lyu CJ
    J Korean Med Sci; 2012 Sep; 27(9):1066-72. PubMed ID: 22969254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary pineal rhabdomyosarcoma successfully treated by high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation: case report.
    Ishi Y; Yamaguchi S; Iguchi A; Cho Y; Ohshima J; Hatanaka KC; Takakuwa E; Kobayashi H; Terasaka S; Houkin K
    J Neurosurg Pediatr; 2016 Jul; 18(1):41-5. PubMed ID: 26942266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.
    Koscielniak E; Klingebiel TH; Peters C; Hermann J; Burdach ST; Bender-Götze C; Müller-Weihrich ST; Treuner J
    Bone Marrow Transplant; 1997 Feb; 19(3):227-31. PubMed ID: 9028550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma.
    Carli M; Colombatti R; Oberlin O; Stevens M; Masiero L; Frascella E; Koscielniak E; Treuner J; Pinkerton CR
    J Clin Oncol; 1999 Sep; 17(9):2796-803. PubMed ID: 10561355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma.
    Kremens B; Gruhn B; Klingebiel T; Hasan C; Laws HJ; Koscielniak E; Hero B; Selle B; Niemeyer C; Finckenstein FG; Schulz A; Wawer A; Zintl F; Graf N
    Bone Marrow Transplant; 2002 Dec; 30(12):893-8. PubMed ID: 12476282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for advanced testicular cancer with high-dose chemotherapy and autologous blood stem cell transplantation.
    Takahashi A; Miyao N; Masumori N; Takeda K; Shigyo M; Sasamura H; Sakamaki S; Niitsu Y; Tsukamoto T
    Int J Urol; 1998 Jan; 5(1):67-72; discussion 73. PubMed ID: 9535604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tandem high-dose chemotherapy with topotecan-thiotepa-carboplatin and melphalan-etoposide-carboplatin regimens for pediatric high-risk brain tumors.
    Choi JY; Kang HJ; Hong KT; Hong CR; Lee YJ; Park JD; Phi JH; Kim SK; Wang KC; Kim IH; Park SH; Choi YH; Cheon JE; Park KD; Shin HY
    Int J Clin Oncol; 2019 Dec; 24(12):1515-1525. PubMed ID: 31352632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
    Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
    [No Abstract]   [Full Text] [Related]  

  • 9. Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.
    Breitfeld PP; Lyden E; Raney RB; Teot LA; Wharam M; Lobe T; Crist WM; Maurer HM; Donaldson SS; Ruymann FB
    J Pediatr Hematol Oncol; 2001 May; 23(4):225-33. PubMed ID: 11846301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose chemotherapy and autologous peripheral blood stem cell transplantation with BCVAC regimen followed by maintenance chemotherapy for children with very high risk acute lymphoblastic leukemia.
    Hong CR; Kang HJ; Park KD; Shin HY; Ahn HS
    Int J Hematol; 2018 Mar; 107(3):355-362. PubMed ID: 29052026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of RS-99 protocol for childhood solid tumors.
    Cai JY; Tang JY; Pan C; Xu M; Xue HL; Zhou M; Dong L; Ye QD; Jiang H; Shen SH; Chen J
    World J Pediatr; 2010 Feb; 6(1):43-9. PubMed ID: 20143210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma.
    Weigel BJ; Breitfeld PP; Hawkins D; Crist WM; Baker KS
    J Pediatr Hematol Oncol; 2001; 23(5):272-6. PubMed ID: 11464981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose chemotherapy for children and young adults with stage IV rhabdomyosarcoma.
    Admiraal R; van der Paardt M; Kobes J; Kremer LC; Bisogno G; Merks JH
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006669. PubMed ID: 21154373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
    Weigel BJ; Lyden E; Anderson JR; Meyer WH; Parham DM; Rodeberg DA; Michalski JM; Hawkins DS; Arndt CA
    J Clin Oncol; 2016 Jan; 34(2):117-22. PubMed ID: 26503200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience.
    Avramova B; Jordanova M; Michailov G; Konstantinov D; Christosova I; Bobev D
    J BUON; 2006; 11(4):433-8. PubMed ID: 17309174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.
    Raney RB; Anderson JR; Barr FG; Donaldson SS; Pappo AS; Qualman SJ; Wiener ES; Maurer HM; Crist WM
    J Pediatr Hematol Oncol; 2001 May; 23(4):215-20. PubMed ID: 11846299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?
    Al-Faris N; Al Harbi T; Goia C; Pappo A; Doyle J; Gassas A
    Pediatr Blood Cancer; 2007 Aug; 49(2):190-5. PubMed ID: 17262797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide.
    Arndt CA; Nascimento AG; Schroeder G; Schomberg PJ; Neglia JP; Sencer SF; Silberman TL; Moertel CL; Tillisch JK; Miser JS
    Eur J Cancer; 1998 Jul; 34(8):1224-9. PubMed ID: 9849484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mobilization and collection of autologous peripheral blood stem cells by CIE or IEV protocol in children with malignant solid tumors].
    Zhang Y; Zhang WL; Huang DS; Yang YP; Liu XC; Wu YP
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Jun; 13(6):471-4. PubMed ID: 21672420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma.
    Boulad F; Kernan NA; LaQuaglia MP; Heller G; Lindsley KL; Rosenfield NS; Abramson SJ; Gerald WL; Small TN; Gillio AP; Gulati SC; O'Reilly RJ; Ghavimi F
    J Clin Oncol; 1998 May; 16(5):1697-706. PubMed ID: 9586881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.